A joint initiative of the Wellcome Genome Campus and the RCPath Interspecialty Committee on Molecular Pathology, this course is aimed primarily at trainee pathologists or haematologists. The programme introduces participants to the rapidly evolving field of the molecular diagnosis of cancer. Clinical scientists entering the field of molecular diagnosis are also encouraged to apply.
Wellcome Genome Campus – EMBL, Cambridge, UK
26 novembro a 1 dezembro 2017